Estimation of the Burden of Disease Due to Diabetes Mellitus Type 2 in the Population of Tabasco During the Period 2013–2023

Background: The burden of type 2 diabetes mellitus (T2DM) in Tabasco from 2013 to 2023 has led to a significant loss in quality of life and life years. This study aims to analyze the impact of T2DM on the population of Tabasco, Mexico, during this period. Methods: A descriptive, observational, longitudinal, and retrospective study was conducted in Tabasco, following Feinstein’s guidelines. The study included 2,402,598 individuals, covering the adult study population of Tabasco ( n = 927,047) based on National Institute of Statistics and Geography (INEGI) data. Data were gathered from the General Directorate of Health Information and the Ministry of Health and analyzed using Microsoft Excel, applying central tendency and dispersion measures, and calculating Disability-Adjusted Life Years (DALYs) with validated formulas. Results: DALYs in Tabasco’s adult population from 2013 to 2023 were 23,049 in 2013, 24,576 in 2014, 25,193 in 2015, 34,361 in 2016, 29,771 in 2017, 29,309 in 2018, 29,959 in 2019, 28,087 in 2020, 26,451 in 2021, 23,502 in 2022, and 30,523 in 2023, totaling 304,781 DALYs for the period. Conclusions: T2DM has shown an increase in incidence and mortality, especially in recent years, leading to a significant rise in DALYs. This reflects a higher disease burden in Tabasco compared to other regions in Mexico and the Americas, resulting in a considerable loss of quality of life and life years.